Windward Capital Management CO Gilead Sciences, Inc. Transaction History

Windward Capital Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 10, 2018	SELL	$71.28 - $78.92 $2.88 Million - $3.19 Million	-40,374 Closed	0 $0
Q2 2018 Jul 12, 2018	SELL	$64.88 - $75.68 $8,369 - $9,762	-129 Reduced 0.32%	40,374 $2.86 Million
Q1 2018 Apr 12, 2018	SELL	$72.84 - $88.8 $2,913 - $3,552	-40 Reduced 0.1%	40,503 $3.05 Million
Q4 2017 Jan 11, 2018	SELL	$71.15 - $83.52 $16,506 - $19,376	-232 Reduced 0.57%	40,543 $2.9 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.94 Million - $3.49 Million	40,775	40,775 $3.3 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Windward Capital Management CO , based on Form 13F filings with the SEC.

Stay updated on Windward Capital Management CO with notifications on news.